
|Articles|July 1, 2002
New test helps patients self-monitor for AMD lesions
Author(s)Lynda Charters
Tel Aviv, Israel-The macular computerized psychophysical test (MCPT)-a new test for monitoring patients with age-related macular degeneration (AMD)-seems to be an efficient method for self-detection of AMD-related lesions, according to Anat Loewenstein, MD.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves veligrotug-vvze (Lumvoa) for thyroid eye disease across active and chronic stages
2
Detecting peripheral retinal lesions in children with myopia
3
4DMT completes enrollment in 4FRONT-2, global phase 3 trial of 4D-150 in wet AMD
4
FDA grants priority review to Satralizumab sBLA for thyroid eye disease
5


























